Michael Fleischhacker
Overview
Explore the profile of Michael Fleischhacker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
910
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Fleischhacker M, Arslan E, Reinicke D, Eisenmann S, Theil G, Kollmeier J, et al.
Diagnostics (Basel)
. 2023 Jul;
13(13).
PMID: 37443525
Notwithstanding some improvement in the earlier detection of patients with lung cancer, most of them still present with a late-stage disease at the time of diagnosis. Next to the most...
2.
Bronkhorst A, Ungerer V, Diehl F, Anker P, Dor Y, Fleischhacker M, et al.
Hum Genet
. 2020 Oct;
140(4):565-578.
PMID: 33123832
Cell-free DNA (cfDNA) has become widely recognized as a promising candidate biomarker for minimally invasive characterization of various genomic disorders and other clinical scenarios. However, among the obstacles that currently...
3.
Lippi G, Betsou F, Cadamuro J, Cornes M, Fleischhacker M, Fruekilde P, et al.
Clin Chem Lab Med
. 2019 Feb;
57(7):974-981.
PMID: 30710481
The European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE) was originally established in 2013, with the main aims of (i) promoting the...
4.
Fleischhacker M, Schmidt B
Transl Lung Cancer Res
. 2019 Feb;
7(Suppl 4):S367-S369.
PMID: 30705858
No abstract available.
5.
Oussalah A, Rischer S, Bensenane M, Conroy G, Filhine-Tresarrieu P, Debard R, et al.
EBioMedicine
. 2018 Apr;
30:138-147.
PMID: 29627389
Background: Patients with cirrhosis are at high risk of hepatocellular carcinoma (HCC). The SEPT9 gene is a key regulator of cell division and tumor suppressor whose hypermethylation is associated with...
6.
Schmidt B, Reinicke D, Reindl I, Bork I, Wollschlager B, Lambrecht N, et al.
Clin Chim Acta
. 2017 May;
469:208.
PMID: 28477842
No abstract available.
7.
Schmidt B, Reinicke D, Reindl I, Bork I, Wollschlager B, Lambrecht N, et al.
Clin Chim Acta
. 2017 Apr;
469:94-98.
PMID: 28373054
Background: In most research laboratories the use of EDTA tubes for the isolation of plasma DNA from tumor patients is standard. Unfortunately these tubes do not allow for an extended...
8.
Schmidt B, Rehbein G, Fleischhacker M
Adv Exp Med Biol
. 2016 Oct;
924:33-37.
PMID: 27753015
Extracellular miRNAs cannot only be isolated from different body fluids like plasma and serum, but also from bronchial lavage samples (BL) obtained by bronchoscopy. Alterations in the expression of microRNAs...
9.
Rehbein G, Schmidt B, Fleischhacker M
Clin Chim Acta
. 2015 Aug;
450:78-82.
PMID: 26232753
Objective: The detection of tumor-associated microRNA expression in bronchial lavage (BL) samples of lung cancer patients could improve the non-invasive tumor diagnostic. Methods: The profile of extracellular microRNAs in bronchial...
10.
Ajona D, Razquin C, Pastor M, Pajares M, Garcia J, Cardenal F, et al.
PLoS One
. 2015 Mar;
10(3):e0119878.
PMID: 25799154
Molecular markers in bronchial fluids may contribute to the diagnosis of lung cancer. We previously observed a significant increase of C4d-containing complement degradation fragments in bronchoalveolar lavage (BAL) supernatants from...